Joint Working between Roche and the NHS

joint working

At Roche we firmly believe that better patient care can be achieved through Joint Working with the NHS. This is why we support and actively implement theDepartment of Health guidance on Joint Working

What is Joint Working?

Joint Working is defined in theDepartment of Health guidance on Joint Working as:

Situations where, for the benefit of patients, one or more pharmaceutical companies and the NHS pool skills, experience and/or resources for the joint development and implementation of patient centred projects and share a commitment to successful delivery

Roche has successfully worked and continues to work alongside national, regional, and local NHS organisations to support and implement developments in healthcare delivery for the benefits of patients

Our Joint Working projects to date have aimed to:

  • Improve quality throughout a patient's healthcare pathway
  • Implement alternative models of care to increase patient access to care
  • Support redesign of disease management services
  • Better use of data to measure healthcare outcomes and reduce inequalities
  • Enable NHS spending to translate into better healthcare outcomes
  • Share good clinical practice across the NHS

All of this we believe can lead to patient benefits – access to quality healthcare services, and better healthcare outcomes.

Below is a list of Joint Working projects Roche is currently involved in. Click on the Executive Summary links below to learn more:

List of Joint Working projects Roche is currently involved in
Improving routine follow up in patients with Inflammatory Arthritis and developing efficient pathways for biological therapies use December 2014 Salford Royal NHS Foundation Trust and Roche Products Ltd (282 KB)
Development of a tool to measure impact on quality of life for a patient with advanced stage Melanoma December 2014 East and North Hertfordshire NHS Trust and Roche Products Ltd. (332 KB)
Improving Outcomes for Cancer Patients – supporting development of a national Systemic Anti-Cancer Therapy (SACT) Dataset for Wales October 2014 SWCN: Hywel Dda University Health Board & Roche Products Ltd (35 KB)
Improving Outcomes for Cancer Patients – demonstrating utility and value of the mandated Systemic Anti-Cancer Therapy (SACT) Dataset through automated reports October 2014
Imperial College Healthcare NHS Trust & Roche Products Ltd.
(36 KB)
SACT: Improving Outcomes for Cancer Patients – demonstrating utility and value of the mandated Systemic Anti-Cancer Therapy (SACT) Dataset through automated reports) June
2014
East and North Hertfordshire NHS Trust and Roche Products Ltd. (35 KB)
SACT - Improving Outcomes for Cancer Patients – supporting development of a national Systemic Anti-Cancer Therapy (SACT) Dataset for Wales May
2014
Singleton Hospital, Swansea; (part of ABMU Health Board ), Velindre NHS Trust and Roche Products Ltd. (36 KB)
SACT - Improving Outcomes for Cancer Patients – meeting compliance with the mandated Systemic Anti-Cancer Therapy Dataset January 2014 The Christie NHS Foundation Trust and Roche Products Ltd. (34 KB)
Commissioning for Quality in Rheumatoid Arthritis November 2013 CQRA and Roche (359 KB)
SACT - Summary of SACT Joint Working Projects October 2013 Roche Products Ltd and NHS (34 KB)


To see the completed Roche Joint Working Projects, clickhere.

For further information on existing Joint Working projects or to explore Joint Working opportunities with Roche pleasecontact us.